FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079809162> ?p ?o ?g. }

• W2079809162 endingPage "60" @default.
• W2079809162 startingPage "256" @default.
• W2079809162 abstract "Evidence suggests that the newer antidepressant drugs may differ with respect to their effects on body weight, especially during long-term treatment. However, the published data about treatment-emergent weight change with the newer antidepressants are limited. Most reports of unexpected selective serotonin reuptake inhibitor (SSRI)-associated weight gain are anecdotal or from small controlled trials. To determine if differences exist among the newer antidepressants, the authors retrospectively analyzed data from clinical trials comparing nefazodone with SSRIs and with imipramine.Weight change data supplied by Bristol-Myers Squibb from 6 completed clinical trials comparing the antidepressant nefazodone (N = 523) with 3 SSRIs, fluoxetine, sertraline, and paroxetine (N = 513), as well as 3 trials comparing nefazodone (N = 225) with the tricyclic antidepressant imipramine (N = 224) were analyzed. In all studies, nefazodone was found to be equal in efficacy to the comparator antidepressants. Studies that included both acute and long-term treatment phases were included in the analysis. Acute phases of the trials lasted either 6 or 8 weeks, and long-term phases varied in duration from 16 to 46 weeks. The analysis included summarizing the number and percentage of patients in each group with a > or = 7% change in body weight from baseline at any point in the long-term and acute phases, at endpoint, and at week 16 of the long-term phases.Using 7% or greater weight change as the measure of clinical significance, 4.3% of SSRI-treated patients had lost weight at any point in the acute phase versus 1.7% of those treated with nefazodone (p = .017). However, at any point during the long-term phase, significantly more SSRI-treated patients than nefazodone-treated patients showed a significant increase in body weight (17.9% vs. 8.3%; p = .003). At any point in the acute phase, significantly more imipramine-treated patients than nefazodone-treated patients had a 7% or greater increase in body weight (4.9% vs. 0.9%; p = .027), and for the long-term phase the comparison yielded 24.5% versus 9.5%. The difference during the long-term phase was statistically significant in women (p = .017), but not in men (p = .078) due to the small numbers of men in each group.SSRIs caused more weight loss during short-term treatment but more weight gain during long-term treatment. These results lend support to the observation that some antidepressants have a greater expected risk of weight gain than others during long-term therapy." @default.
• W2079809162 created "2016-06-24" @default.
• W2079809162 creator A5010117862 @default.
• W2079809162 creator A5060394440 @default.
• W2079809162 creator A5066050830 @default.
• W2079809162 date "2001-04-01" @default.
• W2079809162 modified "2023-10-17" @default.
• W2079809162 title "Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials." @default.
• W2079809162 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11379839" @default.
• W2079809162 hasPublicationYear "2001" @default.
• W2079809162 type Work @default.
• W2079809162 sameAs 2079809162 @default.
• W2079809162 citedByCount "51" @default.
• W2079809162 countsByYear W20798091622012 @default.
• W2079809162 countsByYear W20798091622013 @default.
• W2079809162 countsByYear W20798091622014 @default.
• W2079809162 countsByYear W20798091622015 @default.
• W2079809162 countsByYear W20798091622016 @default.
• W2079809162 countsByYear W20798091622017 @default.
• W2079809162 countsByYear W20798091622018 @default.
• W2079809162 countsByYear W20798091622019 @default.
• W2079809162 countsByYear W20798091622020 @default.
• W2079809162 countsByYear W20798091622021 @default.
• W2079809162 crossrefType "journal-article" @default.
• W2079809162 hasAuthorship W2079809162A5010117862 @default.
• W2079809162 hasAuthorship W2079809162A5060394440 @default.
• W2079809162 hasAuthorship W2079809162A5066050830 @default.
• W2079809162 hasConcept C126322002 @default.
• W2079809162 hasConcept C142724271 @default.
• W2079809162 hasConcept C15744967 @default.
• W2079809162 hasConcept C170493617 @default.
• W2079809162 hasConcept C203092338 @default.
• W2079809162 hasConcept C204787440 @default.
• W2079809162 hasConcept C2775864247 @default.
• W2079809162 hasConcept C2776134451 @default.
• W2079809162 hasConcept C2777490545 @default.
• W2079809162 hasConcept C2777669559 @default.
• W2079809162 hasConcept C2777828372 @default.
• W2079809162 hasConcept C2779145073 @default.
• W2079809162 hasConcept C2779177272 @default.
• W2079809162 hasConcept C2779419675 @default.
• W2079809162 hasConcept C2780092697 @default.
• W2079809162 hasConcept C2781161787 @default.
• W2079809162 hasConcept C31487548 @default.
• W2079809162 hasConcept C535046627 @default.
• W2079809162 hasConcept C71924100 @default.
• W2079809162 hasConceptScore W2079809162C126322002 @default.
• W2079809162 hasConceptScore W2079809162C142724271 @default.
• W2079809162 hasConceptScore W2079809162C15744967 @default.
• W2079809162 hasConceptScore W2079809162C170493617 @default.
• W2079809162 hasConceptScore W2079809162C203092338 @default.
• W2079809162 hasConceptScore W2079809162C204787440 @default.
• W2079809162 hasConceptScore W2079809162C2775864247 @default.
• W2079809162 hasConceptScore W2079809162C2776134451 @default.
• W2079809162 hasConceptScore W2079809162C2777490545 @default.
• W2079809162 hasConceptScore W2079809162C2777669559 @default.
• W2079809162 hasConceptScore W2079809162C2777828372 @default.
• W2079809162 hasConceptScore W2079809162C2779145073 @default.
• W2079809162 hasConceptScore W2079809162C2779177272 @default.
• W2079809162 hasConceptScore W2079809162C2779419675 @default.
• W2079809162 hasConceptScore W2079809162C2780092697 @default.
• W2079809162 hasConceptScore W2079809162C2781161787 @default.
• W2079809162 hasConceptScore W2079809162C31487548 @default.
• W2079809162 hasConceptScore W2079809162C535046627 @default.
• W2079809162 hasConceptScore W2079809162C71924100 @default.
• W2079809162 hasIssue "4" @default.
• W2079809162 hasLocation W20798091621 @default.
• W2079809162 hasOpenAccess W2079809162 @default.
• W2079809162 hasPrimaryLocation W20798091621 @default.
• W2079809162 hasRelatedWork W2007329912 @default.
• W2079809162 hasRelatedWork W2018067258 @default.
• W2079809162 hasRelatedWork W2031602220 @default.
• W2079809162 hasRelatedWork W2036659243 @default.
• W2079809162 hasRelatedWork W2079507344 @default.
• W2079809162 hasRelatedWork W2079809162 @default.
• W2079809162 hasRelatedWork W2086554774 @default.
• W2079809162 hasRelatedWork W2090977130 @default.
• W2079809162 hasRelatedWork W2169568318 @default.
• W2079809162 hasRelatedWork W4300833113 @default.
• W2079809162 hasVolume "62" @default.
• W2079809162 isParatext "false" @default.
• W2079809162 isRetracted "false" @default.
• W2079809162 magId "2079809162" @default.
• W2079809162 workType "article" @default.